EFFICIENCY OF USING SINGLE-NUCLEAR CELL CONTAINING STEM CELLS FROM THE AUTOLOGOUS BONE MARROW IN TREATING CHILDREN WITH CEREBRAL PALSY DUE TO ASPHYXIA IN VINMEC TIMES CITY HOSPITAL

Duy Chinh Vũ1,, Thanh Liêm Nguyễn2, Trung Kiên Nguyễn2
1 Vinmec Times City Hospital
2 Vinmec Institute of Stem Cell and Gene Technology

Main Article Content

Abstract

Objective: Research using single - nuclear cell masses containing stem cells from autologous bone marrow in treating children with cerebral cerebral palsy due to  Brain hypoxia at birth was accepted at the Ministry of Science and Technology in September 2018. Initial results showed safety and evidence of effectiveness. The objective of this study is to confirm the effectiveness of a single -nuclear cell masses containing stem cells from autologous bone marrow on a larger sample size in children with cerebral palsy due to lack of oxygen at birth. Subjects and methods: This is a restrospective-perspective combined  conducted in more than 50 cerebral palsy patients due to asphyxia that has been infused the single cell masses containing stem cells from the autologous bone marrow at Vinmec International Hospital. Effectiveness is evaluated at 6 months, 12 months after the first transfusion using Gross Motor Function Measure 88 Items (GMFM-88) and Modified Ashworth Score (MAS). Results: The gross motor function is measured by GMFM-88 and the level of muscle tone are measured by modified Ashworth improved statistical significance at 6 months and 12 months after transfusion of single - nuclear cell masses containing stem cells from autologous bone marrow. Conclusion: Using single -nuclear cell masses containing stem cells from the autologous bone marrow in the treatment of children with cerebral palsy due to  asphyxia is effective.


 

Article Details

References

1. Rosenbaum P, Paneth N, Leviton A et al: A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl 2007, 109:8-14.
2. Pavlichenko N, Sokolova I, Vijde S et al: Mesenchymal stem cells transplantation could be beneficial for treatment of experimental ischemic stroke in rats. Brain Res 2008, 1233:203-213.
3. Nguyen LT, Nguyen AT, Vu CD et al: Outcomes of autologous bone marrow mononuclear cells for cerebral palsy: an open label uncontrolled clinical trial. BMC Pediatr 2017, 17(1):104.
4. Dianne R PR. GROSS MOTOR FUNCTION MEASURE (GMFM) SCORE SHEET. 2013 [cited 2017; Available from: https://canchild.ca/ system/tenon/assets/attachments/000/000/218/original/gmfm-88_and_66_scoresheet.pdf.
5. Richard B MS. Modified Ashworth Scale Instructions. [cited 2017; Available from: http://www.rehabmeasures.org/PDF%20Library/Modified%20Ashworth%20Scale%20Instructions.pdf.
6. Sharma A, Sane H, Gokulchandran N et al: A clinical study of autologous bone marrow mononuclear cells for cerebral palsy patients: a new frontier. Stem Cells Int 2015, 2015:905874.
7. Eggenberger S, Boucard C, Schoeberlein A et al: Stem cell treatment and cerebral palsy: Systemic review and meta-analysis. World J Stem Cells 2019, 11(10):891-903.
8. Lv ZY, Li Y, Liu J: Progress in clinical trials of stem cell therapy for cerebral palsy. Neural Regen Res 2021, 16(7):1377-1382.